首頁 > 市場調查報告書 > 醫療設備

病患監測體外診斷血糖監測

市場調查報告書

商品編碼

1520480

2024-2032 年連續血糖監測系統市場報告（按組成部分、人口統計資料（兒童人口、成人人口）、最終使用者和地區）

Continuous Glucose Monitoring Systems Market Report by Component, Demographics (Child Population, Adult Population ), End User, and Region 2024-2032

出版日期: 2024年07月01日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球連續血糖監測系統市場規模達到67億美元。

連續血糖監測系統 (CGMS) 是一種技術先進的設備，可自動追蹤血糖水平。它們由整合發射器的感測器組成，透過經皮或皮下途徑連續測量組織液中的葡萄糖濃度。然後發射器將訊息傳送到可以夾在衣服上的無線監視器。連續血糖監測系統有助於提供完整的糖尿病概況，提醒血糖水平的高低，檢測模式，並增加患者對身體活動、藥物選擇、食物份量和壓力的了解。與傳統的血糖監測設備相比，CGMS 是無刺的，因為它們可以放置在皮膚上，有助於以快速、無痛的方式提供即時資訊。

連續血糖監測系統市場趨勢：

全球老年人口不斷增加，更容易罹患糖尿病，為市場創造了積極的前景。 CGMS 通常用於測量體內的葡萄糖和胰島素水平，如果血糖和胰島素水平下降或上升到危險水平，則會進一步發出警報。與此一致的是，即時識別低血糖和高血糖情況的產品的廣泛使用有利於市場成長。此外，CGMS 的重大改進和新技術進步有助於檢測糖尿病患者的糖化血紅蛋白 (Hb1ac)，這為市場成長提供了相當大的推動力。此外，人工胰臟設備系統與 CGMS 技術的整合可泵送胰島素並給予最佳劑量以管理患者的血糖水平，這對市場成長產生了積極影響。除此之外，非侵入性 CGMS 設備作為一種方便的替代品的引入、廣泛的研發 (R&D) 活動以及對微創或微創診斷工具不斷成長的需求預計將推動市場進一步成長。

本報告回答的關鍵問題

2023年全球連續血糖監測系統市場規模有多大？
2024-2032年全球連續血糖監測系統市場的預期成長率為何？
COVID-19 對全球連續血糖監測系統市場有何影響？
推動全球連續血糖監測系統市場的關鍵因素是什麼？
基於組件的全球連續血糖監測系統市場的詳細情形如何？
根據人口統計數據，全球連續血糖監測系統市場的細分如何？
基於最終用戶的全球連續血糖監測系統市場的細分是什麼？
全球連續血糖監測系統市場的關鍵區域有哪些？
全球連續血糖監測系統市場的主要參與者/公司有哪些？

市場結構
關鍵參與者
關鍵參與者簡介
- A. Menarini Diagnostics Srl
- Abbott Laboratories
- DexCom Inc.
- F. Hoffmann-La Roche AG
- Glysens Incorporated
- LifeScan Inc. (Johnson & Johnson)
- Medtronic PLC
- Medtrum Technologies Inc.
- Nemaura Medical Inc.
- Novo Nordisk A/S
- Senseonics Holdings Inc.
- Waveform Technologies Inc.

簡介目錄圖表

Product Code: SR112024A5377

The global continuous glucose monitoring systems market size reached US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032.

Continuous glucose monitoring systems (CGMS) are technologically advanced devices that automatically track blood glucose levels. They consist of a transmitter-integrated sensor that functions through a transcutaneous or subcutaneous route to continuously measure the glucose concentration in interstitial fluid. The transmitter then sends the information to a wireless monitor that can be clipped to clothes. Continuous glucose monitoring systems assist in providing a complete profile of diabetes, alerting highs and lows of blood sugar levels, detecting patterns, and increasing patient insights regarding physical activity, medication choices, food portions and stress. As compared to conventional glucose monitoring devices, CGMS are prick-free as they can be placed over the skin, thus aiding in providing real-time information in a quick and painless fashion.

Continuous Glucose Monitoring Systems Market Trends:

The rising geriatric population across the globe that are more susceptible to developing diabetes is creating a positive outlook for the market. CGMS is commonly used for measuring glucose and insulin level in the body, which further sounds an alarm if it drops or rises to a dangerous level. In line with this, the widespread product utilization to identify hypoglycemia and hyperglycemic situations in real-time is favoring the market growth. Moreover, significant improvements and new technological advancements in CGMS that aid in detecting glycated hemoglobin (Hb1ac) in patients with diabetes are providing a considerable boost to the market growth. Additionally, the integration of artificial pancreas device systems with CGMS technology to pump insulin and administer optimum dosage to manage the blood sugar levels of patients is positively impacting the market growth. Apart from this, the introduction of non-invasive CGMS devices as a convenient alternative, extensive research and development (R&D) activities and the increasing demand for less or minimally invasive diagnostic tools are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global continuous glucose monitoring systems market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, demographics and end user.

Breakup by Component:

Sensors

Transmitters and Receivers

Integrated Insulin Pumps

Breakup by Demographics:

Child Population (<=14 years)

Adult Population (>14 years)

Breakup by End User:

Clinics and Diagnostics Centers

ICUs

Home Healthcare

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

Key Questions Answered in This Report

1. What was the size of the global continuous glucose monitoring systems market in 2023?
2. What is the expected growth rate of the global continuous glucose monitoring systems market during 2024-2032?
3. What has been the impact of COVID-19 on the global continuous glucose monitoring systems market?
4. What are the key factors driving the global continuous glucose monitoring systems market?
5. What is the breakup of the global continuous glucose monitoring systems market based on the component?
6. What is the breakup of the global continuous glucose monitoring systems market based on the demographics?
7. What is the breakup of the global continuous glucose monitoring systems market based on end user?
8. What are the key regions in the global continuous glucose monitoring systems market?
9. Who are the key players/companies in the global continuous glucose monitoring systems market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Continuous Glucose Monitoring Systems Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Component

6.1 Sensors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Transmitters and Receivers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Integrated Insulin Pumps
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Demographics

7.1 Child Population (<=14 years)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Adult Population (>14 years)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Clinics and Diagnostics Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 ICUs
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Home Healthcare
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 A. Menarini Diagnostics S.r.l.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Abbott Laboratories
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 DexCom Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche AG
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Glysens Incorporated
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 LifeScan Inc. (Johnson & Johnson)
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 SWOT Analysis
- 14.3.7 Medtronic PLC
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Medtrum Technologies Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Nemaura Medical Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
- 14.3.10 Novo Nordisk A/S
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Senseonics Holdings Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
- 14.3.12 Waveform Technologies Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Continuous Glucose Monitoring Systems Market: Major Drivers and Challenges
Figure 2: Global: Continuous Glucose Monitoring Systems Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Continuous Glucose Monitoring Systems Market: Breakup by Component (in %), 2023
Figure 5: Global: Continuous Glucose Monitoring Systems Market: Breakup by Demographics (in %), 2023
Figure 6: Global: Continuous Glucose Monitoring Systems Market: Breakup by End User (in %), 2023
Figure 7: Global: Continuous Glucose Monitoring Systems Market: Breakup by Region (in %), 2023
Figure 8: Global: Continuous Glucose Monitoring Systems (Sensors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Continuous Glucose Monitoring Systems (Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Continuous Glucose Monitoring Systems (Transmitters and Receivers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Continuous Glucose Monitoring Systems (Integrated Insulin Pumps) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Continuous Glucose Monitoring Systems (Child Population (<=14 years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Continuous Glucose Monitoring Systems (Adult Population (>14 years)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Continuous Glucose Monitoring Systems (Clinics and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Continuous Glucose Monitoring Systems (ICUs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Continuous Glucose Monitoring Systems (ICUs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Continuous Glucose Monitoring Systems (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: North America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: North America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: United States: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Canada: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Canada: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Asia-Pacific: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Asia-Pacific: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: China: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: China: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Japan: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Japan: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: India: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: India: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: South Korea: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: South Korea: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Australia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Australia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Indonesia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Indonesia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Europe: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Europe: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Germany: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Germany: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: France: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: France: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: United Kingdom: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: United Kingdom: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Italy: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Italy: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Spain: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Spain: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Russia: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Russia: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Latin America: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Latin America: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Brazil: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Brazil: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Mexico: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Mexico: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Middle East and Africa: Continuous Glucose Monitoring Systems Market: Breakup by Country (in %), 2023
Figure 72: Middle East and Africa: Continuous Glucose Monitoring Systems Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Global: Continuous Glucose Monitoring Systems Industry: SWOT Analysis
Figure 74: Global: Continuous Glucose Monitoring Systems Industry: Value Chain Analysis
Figure 75: Global: Continuous Glucose Monitoring Systems Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Continuous Glucose Monitoring Systems Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Demographics (in Million US$), 2024-2032
Table 4: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Continuous Glucose Monitoring Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Continuous Glucose Monitoring Systems Market: Competitive Structure
Table 7: Global: Continuous Glucose Monitoring Systems Market: Key Players

02-2729-4219

+886-2-2729-4219